SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Quick Heal Technologies Ltd (QUICKHEAL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 539678 NSE: QUICKHEAL IT - Software | Small Cap | Quick Heal Tech Share Price

₹182.30 0.45 (0.25%)

As on 04-Jun'26 16:59

Quick Heal Technologies Ltd (QUICKHEAL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 539678 NSE: QUICKHEAL IT - Software | Small Cap | Quick Heal Tech Share Price

₹182.30 0.45 (0.25%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹1,040 Cr.
Current Price
₹182.3
52-Week Low / High
₹125 / 416
TTM EPS
₹-2
TTM Sales
₹261 Cr.
Book Value per Share
₹80.5
P/E Ratio
0.00
Lower than its 5-year historical median
Industry PE
23.6
Price to Book (P/B)
2.38
Lower than its 5-year historical median
Price to Sales (P/S)
3.99
Lower than its 5-year historical median
EV/EBITDA
-157.07
Lower than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
1.18%
Underperforms industry median
Return on Capital Employed (ROCE)
0.28%
Underperforms industry median
Return on Assets (ROA)
0.98%
Operating Profit Margin
-2.4%
Net Profit Margin
1.8%
Gross Profit Margin
5%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
-4.19%
Operating Profit Growth (1 Year)
-
-137.55%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-79.21%
Asset Quality
Promoter Holding
71.50%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹382 Cr.
Equity
₹54.3 Cr.
Face Value
₹10
All Time Low / High
₹62.45 / 825.90

Quick Heal Technologies stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Fair

Price Trend

Semi Strong
Q.1 Is Quick Heal Technologies Ltd a good quality company?
Quick Heal Technologies Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Quick Heal Technologies Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Quick Heal Technologies Ltd vs industry peers?
Quick Heal Technologies Ltd revenue CAGR is -0.47%, compared to the industry median CAGR of 2.48%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Quick Heal Technologies Ltd?
Promoters hold 71.50% of the Quick Heal Technologies Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Quick Heal Technologies Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of -1.9% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Quick Heal Technologies Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 18.3%13%17.8%18.1%14.1%20.9%15.8%1.5%6.2%0.3%-
Value Creation
Index
0.3-0.10.30.30.00.50.1-0.9-0.6-1.0-

Growth Parameters

Sales 302300318315286333342278292280261
Sales YoY Gr.--0.7%6.1%-1.1%-9.1%16.4%2.7%-18.7%4.9%-4.2%-
Adj EPS 8.2811.112.811.216.313.80.440.6-2
YoY Gr.--2.6%38.9%15.3%-12.3%45.8%-15.5%-97.4%1016.7%-84.6%-
BVPS (₹) 89.794.2102.6111.699.9116.610777.379.87980.5
Adj Net
Profit
57.4567890.27210580.11.921.53.4-11
Cash Flow from Ops. 77.735.893.961.470.698.68030.818.2-22.3-
Debt/CF from Ops. 0000000000-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales -0.9%-0.5%-6.5%-4.2%
Adj EPS -24.9%-44%-64.5%-84.6%
BVPS-1.4%-4.6%-9.6%-1.1%
Share Price -2.7% -4.6% 8% -48.3%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
128.711.311.9101511.60.450.8-2.5
Op. Profit
Mgn %
33.730.137.840.631.941.431.30.96.1-2.4-11.3
Net Profit
Mgn %
1918.724.528.625.231.523.40.77.41.2-4.2
Debt to
Equity
00000000000
Working Cap
Days
135160146153183176201235201235272
Cash Conv.
Cycle
835486477568811888139198

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales302300318315286333342278292280
Operating Expenses > + 200210198187195195235276274286
Manufacturing Costs61877665565
Material Costs17141313101212977
Employee Cost 8710310299101115139155169186
Other Costs > 917576697763781079388
Operating Profit > 1029012012891138107218-7
Operating Profit Margin (%) 33.7%30.1%37.8%40.6%31.9%41.3%31.3%0.7%6.0%-2.4%
Other Income > + 10283033322819222121
Exceptional Items > 0-400000000
Interest > 0000000000
Depreciation > 24312724221917161313
Profit Before Tax > 88841231371011461098261
Tax > 3031404527392522-4
Profit After Tax 5853839274107836245
PAT Margin (%) 19.2%17.7%26.1%29.2%26.0%32.1%24.3%2.3%8.3%1.8%
Adjusted EPS (₹)8.37.611.813.011.616.714.31.24.50.9
Dividend Payout Ratio (%)30.20%32.90%25.40%15.40%34.50%24%31.40%207.30%66.20%0%

Valuation of Quick Heal Tech - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 628660722788642748621410427426
Share Capital 70707071646458535454
Reserves 558590652717577684563357374372
Debt +0000000000
Long Term Debt0000000000
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables51413339395050494035
Others Liabilities 30242118142846344256
Total Liabilities 710725776844694827716493509517

Fixed Assets

Net Fixed Assets +1421851731651581461121008584
Gross Block206277292305311316281279261268
Accumulated Depreciation6492119140153171169179176183
CWIP 55141411320030
Investments 115182306390310416318198190179
Inventories7865635532
Trade Receivables9297103125113151172123132167
Cash Equivalents 269209163135808463123821
Others Assets 29301114232547565964
Total Assets 710725776844694827716493509517

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 783694617199803118-22
PBT 88841231371011461098261
Adjustment 1699-33010467
Changes in Working Capital -10-27-13-17-1-19-527-14-29
Tax Paid -16-30-26-55-33-29-33-80-1
Cash Flow From Investing Activity + -163-73-122-37148-92126185616
Capex -36-34-13-8-10-9-11-6-14
Net Investments -132-62-128-56141-91124179724
Others 52419271683566
Cash Flow From Financing Activity + 189-20-19-24-2210-214-2122-10
Net Proceeds from Shares 238131002166
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid -40-18-18-21-380-23-26-13-16
Others -8-4-4-4-1830-193-1879-0
Net Cash Flow 104-57-471-36-9426-17

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)12.078.2612.0112.1610.4115.3912.151.245.791.18
ROCE (%)18.3412.9917.8218.114.1320.9415.761.536.150.28
Asset Turnover Ratio0.530.420.420.390.370.440.440.460.580.54
PAT to CFO Conversion(x)1.340.681.130.660.960.930.965.170.75-4.4
Working Capital Days
Receivable Days94.90115.30114.80132.20151.90144.60172.20193.30159.10194.90
Inventory Days8.808.907.806.407.405.304.306.104.603.30
Payable Days956.201,165.401,037.401,026.401,411.201,3921,4961,9232,364.501,914.80

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Quick Heal Technologies Ltd FAQs

The current trading price of Quick Heal Tech on 04-Jun-2026 16:59 is ₹182.3.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Quick Heal Tech stood at ₹1,040.5 Cr

The latest P/E ratio of Quick Heal Tech as of 03-Jun-2026 is 0.00.

The latest P/B ratio of Quick Heal Tech as of 03-Jun-2026 is 2.38.

The 52-week high of Quick Heal Tech is ₹416.0 and the 52-week low is ₹125.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Quick Heal Tech is ₹261 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Quick Heal Technologies Ltd is a good quality company.

The key valuation ratios of Quick Heal Technologies Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Quick Heal Technologies Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Quick Heal Technologies Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×